Johnson & Johnson oferă până la 5,5 miliarde de dolari pentru a soluționa procesele privind pudra pentru bebeluși care ar cauza cancer

Johnson & Johnson has allocated up to $5.5 billion to settle thousands of lawsuits claiming its talc products caused ovarian cancer. The company aims to pay up to $3 billion by 2027, with remaining claims settled afterward. Approximately 76,000 claims are involved, requiring approval from 95% of the plaintiffs' attorneys. Despite ongoing allegations regarding asbestos in its talc products, Johnson & Johnson maintains that its products are safe. The company discontinued talc-based baby powder in North America in 2020, citing product portfolio simplification. Legal outcomes have varied, with some cases resulting in substantial damages against the company.